Academic literature on the topic 'Inactive surface mutants'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Inactive surface mutants.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Journal articles on the topic "Inactive surface mutants"
1
Honegger, A. M., A. Schmidt, A. Ullrich, and J. Schlessinger. "Separate endocytic pathways of kinase-defective and -active EGF receptor mutants expressed in same cells." Journal of Cell Biology 110, no. 5 (May 1, 1990): 1541–48. http://dx.doi.org/10.1083/jcb.110.5.1541.
Full textAbstract:
Ligand binding to the membrane receptor for EGF induces its clustering and internalization. Both receptor and ligand are then degraded by lysosomal enzymes. A kinase defective point mutant (K721A) of EGF receptor undergoes internalization similarly to the wild-type receptor. However, while internalized EGF molecules bound to either the wild-type or mutant receptors are degraded, the K721A mutant receptor molecules recycle to the cell surface for reutilization. To investigate the mechanism of receptor trafficking, we have established transfected NIH-3T3 cells coexpressing the kinase-negative mutant (K721A) together with a mutant EGF receptor (CD63) with active kinase. CD63 was chosen because it behaves like wild-type EGF receptor with respect to biological responsiveness and cellular routing but afforded immunological distinction between kinase active and inactive mutants. Although expressed in the same cells, the two receptor mutants followed their separate endocytic itineraries. Like wild-type receptor, the CD63 mutant was downregulated and degraded in response to EFG while the kinase-negative mutant K721A returned to the cell surface for reutilization. Intracellular trafficking of EGF receptor must be determined by a sorting mechanism that specifically recognizes EGF receptor molecules according to their intrinsic kinase activity.
2
Mo, Xiu-Lei, Rui Yang, and Ya-Xiong Tao. "Functions of transmembrane domain 3 of human melanocortin-4 receptor." Journal of Molecular Endocrinology 49, no. 3 (September 26, 2012): 221–35. http://dx.doi.org/10.1530/jme-12-0162.
Full textAbstract:
The melanocortin-4 receptor (MC4R) is a G protein-coupled receptor critical for maintaining energy homeostasis. Transmembrane domain 3 (TM3) of MC4R contains residues that were suggested to be essential in ligand binding and signaling. SeveralMC4Rmutations in TM3 are associated with human obesity. To gain a better understanding of the functions of TM3, we analyzed the functions of 26 residues in TM3 using alanine-scanning mutagenesis. We showed that all mutants had normal cell-surface expression. Four mutants were defective in ligand binding and signaling and six mutants had normal ligand binding but impaired cAMP production. L140A had increased basal cAMP level. To further characterize the function of L140, we generated 17 additional L140 mutants. Fifteen L140 mutants had significantly decreased cell-surface expression, with L140R and L140V expressed normally. Ten L140 mutants had increased basal cAMP activities. Four L140 mutants were defective in ligand-stimulated cAMP generation. Interestingly, with the ERK1/2 pathway, we showed that nine constitutively active mutants had similar levels of basal pERK1/2 as that of WT, and two signaling defective mutants had similar levels of pERK1/2 as that of WT upon agonist stimulation, different from their cAMP signaling properties, suggesting biased signaling in these mutant receptors. In summary, we identified 13 residues in TM3 that were essential for ligand binding and/or signaling. Moreover, L140 was critical for locking MC4R in inactive conformation and several mutants showed biased signaling in cAMP and ERK1/2 signaling pathways.
3
Kinne, Anita, Stephan Roth, Heike Biebermann, Josef Köhrle, Annette Grüters, and Ulrich Schweizer. "Surface translocation and tri-iodothyronine uptake of mutant MCT8 proteins are cell type-dependent." Journal of Molecular Endocrinology 43, no. 6 (July 31, 2009): 263–71. http://dx.doi.org/10.1677/jme-09-0043.
Full textAbstract:
Mutations in the gene encoding the thyroid hormone transporter, monocarboxylate transporter 8 (MCT8), underlie severe mental retardation. We wanted to understand the functional consequences of a series of missense mutations in MCT8 in order to identify therapeutic options for affected patients. We established cell lines stably expressing 12 MCT8 variants in JEG1 and MDCK1 cells. The cell lines were characterized according to MCT8 mRNA and protein expression, tri-iodothyronine (T3) transport activity, substrate KM characteristics, surface expression, and responsiveness to T3 preincubation and chemical chaperones. Functional activities of ins235V and L568P MCT8 mutants depend on the cell type in which they are expressed. These mutants and R271H exhibited considerable transport activity when present at the cell surface as verified by surface biotinylation and kinetic analysis. Most mutants, however, were inactive in T3 transport even when present at the cell surface (e.g. S194F, A224V, ΔF230, L512P). Preincubation of G558D with T3 increased T3 uptake in MDCK1 cells to a small, but significant, extent. Chemical chaperones were ineffective. The finding that the cell type determines surface expression and T3 transport activities of missense mutants in MCT8 may be important to understand phenotypic variability among carriers of different mutations. In particular, the clinical observation that the severity of derangements of thyroid hormone levels does not correlate with mental impairments of the patients may be based on different residual activity of mutant MCT8 in different cell types.
4
Filippa, Nathalie, Carol L. Sable, Brian A. Hemmings, and Emmanuel Van Obberghen. "Effect of Phosphoinositide-Dependent Kinase 1 on Protein Kinase B Translocation and Its Subsequent Activation." Molecular and Cellular Biology 20, no. 15 (August 1, 2000): 5712–21. http://dx.doi.org/10.1128/mcb.20.15.5712-5721.2000.
Full textAbstract:
ABSTRACT In this report we investigated the function of phosphoinositide-dependent protein kinase 1 (PDK1) in protein kinase B (PKB) activation and translocation to the cell surface. Wild-type and PDK1 mutants were transfected into HeLa cells, and their subcellular localization was analyzed. PDK1 was found to translocate to the plasma membrane in response to insulin, and this process did not require a functional catalytic activity, since a catalytically inactive kinase mutant (Kd) of PDK1 was capable of translocating. The PDK1 presence at the cell surface was shown to be linked to phospholipids and therefore to serum-dependent phosphatidylinositol 3-kinase activity. Using confocal microscopy in HeLa cells we found that PDK1 colocalizes with PKB at the plasma membrane. Further, after cotransfection of PKB and a PDK1 mutant (Mut) unable to translocate to the plasma membrane, PKB was prevented from moving to the cell periphery after insulin stimulation. In response to insulin, a PKB mutant with its PH domain deleted (ΔPH-PKB) retained the ability to translocate to the plasma membrane when coexpressed with PDK1. Finally, we found that ΔPH-PKB was highly active independent of insulin stimulation when cotransfected with PDK1 mutants defective in their PH domain. These findings suggest that PDK1 brings PKB to the plasma membrane upon exposure of cells to insulin and that the PH domain of PDK1 acts as a negative regulator of its enzyme activity.
5
Zorreguieta, Angeles, Christine Finnie, and J. Allan Downie. "Extracellular Glycanases of Rhizobium leguminosarum Are Activated on the Cell Surface by an Exopolysaccharide-Related Component." Journal of Bacteriology 182, no. 5 (March 1, 2000): 1304–12. http://dx.doi.org/10.1128/jb.182.5.1304-1312.2000.
Full textAbstract:
ABSTRACT Rhizobium leguminosarum secretes two extracellular glycanases, PlyA and PlyB, that can degrade exopolysaccharide (EPS) and carboxymethyl cellulose (CMC), which is used as a model substrate of plant cell wall cellulose polymers. When grown on agar medium, CMC degradation occurred only directly below colonies of R. leguminosarum, suggesting that the enzymes remain attached to the bacteria. Unexpectedly, when a PlyA-PlyB-secreting colony was grown in close proximity to mutants unable to produce or secrete PlyA and PlyB, CMC degradation occurred below that part of the mutant colonies closest to the wild type. There was no CMC degradation in the region between the colonies. By growing PlyB-secreting colonies on a lawn of CMC-nondegrading mutants, we could observe a halo of CMC degradation around the colony. Using various mutant strains, we demonstrate that PlyB diffuses beyond the edge of the colony but does not degrade CMC unless it is in contact with the appropriate colony surface. PlyA appears to remain attached to the cells since no such diffusion of PlyA activity was observed. EPS defective mutants could secrete both PlyA and PlyB, but these enzymes were inactive unless they came into contact with an EPS+ strain, indicating that EPS is required for activation of PlyA and PlyB. However, we were unable to activate CMC degradation with a crude EPS fraction, indicating that activation of CMC degradation may require an intermediate in EPS biosynthesis. Transfer of PlyB to Agrobacterium tumefaciens enabled it to degrade CMC, but this was only observed if it was grown on a lawn ofR. leguminosarum. This indicates that the surface ofA. tumefaciens is inappropriate to activate CMC degradation by PlyB. Analysis of CMC degradation by other rhizobia suggests that activation of secreted glycanases by surface components may occur in other species.
6
Yamanouchi, Jun, Takaaki Hato, Hiroshi Fujiwara, Yoshihiro Yakushijin, and Masaki Yasukawa. "A Glycan Wedge Between βTD and βI Domains Activates Integrin αIIbβ3,." Blood 118, no. 21 (November 18, 2011): 3259. http://dx.doi.org/10.1182/blood.v118.21.3259.3259.
Full textAbstract:
Abstract Abstract 3259 Integrin αIIbβ3 undergoes allosteric conformational changes in its extracellular domains, resulting in integrin activation that allows high affinity binding with soluble ligands. The crystal structure of the integrin β subunit revealed an interaction of the β-tail domain (βTD) with the βI domain containing ligand-binding sites, suggesting that βTD may be involved in allosteric mechanism for integrin activation. However, previous studies have shown conflicting results on the functional role of βTD in integrin activation. In this study, we conducted site-directed mutagenesis in the βTD domain and tested ligand binding to αIIbβ3 mutants. We produced αIIbβ3 mutants in which the β3TD loop residues (DSSG) were substituted with the corresponding β1 (NGNN) or β2TD residues (DGMD). The αIIbβ3 mutants were expressed on the surface of CHO cells by cotransfection of mutant β3 and wild-type αIIb cDNAs, and were tested for binding of PAC1, a ligand-mimetic anti-αIIbβ3 antibody. The NGNN, but not DGMD mutant bound significant PAC1 binding without any stimulation, indicating a constitutively active state. To identify the residue(s) responsible for αIIbβ3 activation in the βTD, we produced αIIbβ3 mutants in which the individual residues in the β3TD loop were substituted with the corresponding β1TD residues. Among them, only G675N bound significant PAC1 binding without any stimulation. Since G675N mutation creates a sequence known to be a consensus sequence for glycosylation (Asn-X-Ser/Thr), it is possible that the insertion of glycans into the βTD loop induces conformational changes in αIIbβ3 which allow ligand binding. To test this hypothesis, we added substitution of S677 with Thr, Ala or Asp to the G675N mutation. The resultant G675N/S677T double mutant, in which the N-glycosylation site was preserved, was constitutively active. In contrast, G675N/S677A and G675N/S677D, in which the N-glycosylation site was disrupted, were in an inactive state. These results suggest that an artificial glycan wedge between βTD and βI domains activates αIIbβ3. However, our study does not provide evidence that the βTD domain constrains wild type αIIbβ3 inactive although the separation of βTD and βI domains may be able to activate integrins. Disclosures: No relevant conflicts of interest to declare.
7
Moon, Andrea F., Philippe Gaudu, and Lars C. Pedersen. "Structural characterization of the virulence factor nuclease A fromStreptococcus agalactiae." Acta Crystallographica Section D Biological Crystallography 70, no. 11 (October 23, 2014): 2937–49. http://dx.doi.org/10.1107/s1399004714019725.
Full textAbstract:
The group B pathogenStreptococcus agalactiaecommonly populates the human gut and urogenital tract, and is a major cause of infection-based mortality in neonatal infants and in elderly or immunocompromised adults. Nuclease A (GBS_NucA), a secreted DNA/RNA nuclease, serves as a virulence factor forS. agalactiae, facilitating bacterial evasion of the human innate immune response. GBS_NucA efficiently degrades the DNA matrix component of neutrophil extracellular traps (NETs), which attempt to kill and clear invading bacteria during the early stages of infection. In order to better understand the mechanisms of DNA substrate binding and catalysis of GBS_NucA, the high-resolution structure of a catalytically inactive mutant (H148G) was solved by X-ray crystallography. Several mutants on the surface of GBS_NucA which might influence DNA substrate binding and catalysis were generated and evaluated using an imidazole chemical rescue technique. While several of these mutants severely inhibited nuclease activity, two mutants (K146R and Q183A) exhibited significantly increased activity. These structural and biochemical studies have greatly increased our understanding of the mechanism of action of GBS_NucA in bacterial virulence and may serve as a foundation for the structure-based drug design of antibacterial compounds targeted toS. agalactiae.
8
Ferjoux, Geraldine, Frederic Lopez, Jean-Pierre Esteve, Audrey Ferrand, Eric Vivier, Frederic Vely, Nathalie Saint-Laurent, Lucien Pradayrol, Louis Buscail, and Christiane Susini. "Critical Role of Src and SHP-2 in sst2 Somatostatin Receptor-mediated Activation of SHP-1 and Inhibition of Cell Proliferation." Molecular Biology of the Cell 14, no. 9 (September 2003): 3911–28. http://dx.doi.org/10.1091/mbc.e03-02-0069.
Full textAbstract:
The G protein-coupled sst2 somatostatin receptor acts as a negative cell growth regulator. Sst2 transmits antimitogenic signaling by recruiting and activating the tyrosine phosphatase SHP-1. We now identified Src and SHP-2 as sst2-associated molecules and demonstrated their role in sst2 signaling. Surface plasmon resonance and mutation analyses revealed that SHP-2 directly associated with phosphorylated tyrosine 228 and 312, which are located in sst2 ITIMs (immunoreceptor tyrosine-based inhibitory motifs). This interaction was required for somatostatin-induced SHP-1 recruitment and activation and consequent inhibition of cell proliferation. Src interacted with sst2 and somatostatin promoted a transient Gβγ-dependent Src activation concomitant with sst2 tyrosine hyperphosphorylation and SHP-2 activation. These steps were abrogated with catalytically inactive Src. Both catalytically inactive Src and SHP-2 mutants abolished somatostatin-induced SHP-1 activation and cell growth inhibition. Sst2–Src–SHP-2 complex formation was dynamic. Somatostatin further induced sst2 tyrosine dephosphorylation and complex dissociation accompanied by Src and SHP-2 inhibition. These steps were defective in cells expressing a catalytically inactive Src mutant. All these data suggest that Src acts upstream of SHP-2 in sst2 signaling and provide evidence for a functional role for Src and SHP-2 downstream of an inhibitory G protein-coupled receptor.
9
Ebanks, R. O., and D. E. Isenman. "Evidence for the involvement of arginine 462 and the flanking sequence of human C4 beta-chain in mediating C5 binding to the C4b subcomponent of the classical complement pathway C5 convertase." Journal of Immunology 154, no. 6 (March 15, 1995): 2808–20. http://dx.doi.org/10.4049/jimmunol.154.6.2808.
Full textAbstract:
Abstract Replacement of human C4 beta-chain residue arginine 458 by tryptophan, a substitution that occurs naturally in the hemolytically inactive A6 allotype of C4, totally abrogates the molecule's ability to act as a C5 binding subunit of the classical pathway C5 convertase. Hydropathy plots predict R458 to be within a hydrophilic segment extending from residue 455 to 469 and having the sequence SIERPDSRPPRVGDT. To further assess the potential involvement of this segment in the C5 binding function of C4, we have engineered "ala-scan" mutants through this segment, concentrating predominantly on charged residues, and analyzed their functional profiles. C4B isotype mutant proteins S455A (0.7), E457A (1.1), R458A (0.3), D460A (0.2), R462A (0.0), R465A (0.6), and D468A (0.3) displayed the relative to wild-type hemolytic activities indicated in the parentheses. In all cases, the hemolytic defect was accounted for solely at the C5 convertase stage. The total absence of C5 binding activity in the R462A mutant suggests a requirement for the guanidinium group per se, because mutants with a charge-conservative lysine or a relatively isosteric methionine at this position were also completely inactive. In contrast, the inactivity of the C4A6-like R458W mutant is probably caused by the intolerance of tryptophan in a hydrophilic segment, as substitution of R458 by alanine or methionine yielded recombinant molecules that retained 30% and 60% of wild-type hemolytic activity, respectively. Taken together, the mutagenesis results strongly imply that residues in the 455-469 segment contribute to the C5 binding site in C4; however, the conformational context of the segment appears to be crucial, as a synthetic peptide corresponding to this segment displayed no ability to inhibit C5 binding to surface-bound C4b.
10
Ohradanova, Anna, Daniela Vullo, Juraj Kopacek, Claudia Temperini, Tatiana Betakova, Silvia Pastorekova, Jaromir Pastorek, and Claudiu T. Supuran. "Reconstitution of carbonic anhydrase activity of the cell-surface-binding protein of vaccinia virus." Biochemical Journal 407, no. 1 (September 12, 2007): 61–67. http://dx.doi.org/10.1042/bj20070816.
Full textAbstract:
The N-terminal region of a 32 kDa cell-surface-binding protein, encoded by the D8L gene of vaccinia virus, shows sequence homology to CAs (carbonic anhydrases; EC 4.2.1.1). The active CAs catalyse the reversible hydration of CO2 to bicarbonate participating in many physiological processes. The CA-like domain of vaccinia protein [vaccCA (vaccinia virus CA-like protein)] contains one of the three conserved histidine residues required for co-ordination to the catalytic zinc ion and for enzyme activity. In the present study, we report the engineering of catalytically active vaccCA mutants by introduction of the missing histidine residues into the wild-type protein. The wild-type vaccCA was inactive as a catalyst and does not bind sulfonamide CA inhibitors. Its position on a phylogram with other hCAs (human CAs) shows a relationship with the acatalytic isoforms CA X and XI, suggesting that the corresponding viral gene was acquired from the human genome by horizontal gene transfer. The single mutants (vaccCA N92H/Y69H) showed low enzyme activity and low affinity for acetazolamide, a classical sulfonamide CA inhibitor. The activity of the double mutant, vaccCA N92H/Y69H, was much higher, of the same order of magnitude as that of some human isoforms, namely CA VA and CA XII. Moreover, its affinity for acetazolamide was high, comparable with that of the most efficient human isoenzyme, CA II (in the low nanomolar range). Multiplication of vaccinia virus in HeLa cells transfected with the vaccCA N92H/Y69H double mutant was approx. 2-fold more efficient than in wild-type vaccCA transfectants, suggesting that the reconstitution of the enzyme activity improved the virus life cycle.
Dissertations / Theses on the topic "Inactive surface mutants"
1
Lapalus, Martine. "Etude de marqueurs non-invasifs pour prédire la réactivation virale et la sévérité de la fibrose chez les patients atteints d'hépatite chronique B." Paris 7, 2014. http://www.theses.fr/2014PA077248.
Full textAbstract:
L'hépatite chronique B (HCB) peut évoluer vers la cirrhose et le carcinome hépatocellulaire. Mes travaux de thèse ont consisté à évaluer le pouvoir prédictif de marqueurs non-invasifs de l'hôte et du virus vis-à-vis de la réactivation chez les patients AgHBe négatif asymptomatiques et de la sévérité de l'atteinte hépatique. Un total de 129 et 377 patients ont été inclus dans la première et la deuxième étude, respectivement. Dans une première partie, un seuil d'AgHBs > 1000 UI/mL associé à un seuil d'ADN-VHB > 200 UI/mL permet d'identifier dès la première visite les patients AgHBe négatif risquant de réactiver (sensibilité : 92 %, VPN : 96 %). Ces patients doivent être traités pour éviter la progression de la fibrose. Un seuil d'AgHBs < 1000 UI/mL ainsi qu'une décroissance annuelle > 0,3 logioUl/mL permettent de prédire la perte de l'AgHBs (VPP : 89 %, VPN : 95 %). Dans une seconde partie, l'âge (p < 0,0001), les titres d'ALT (p = 0,02) et d'ADN-VHB (p = 0,0006) et la présence de mutants du VHB (promoteur basal du core (BCP) et precore (PC), p < 0,0001) sont indépendamment associés à la fibrose significative (METAVIR > F2). La combinaison de ces 4 variables non-invasives permet de prédire avec précision (c-index = 0,76 [95 % IC 0,71-0,81]) la fibrose significative chez les patients atteints d'HCB. La forte association de la mutation du BCP avec la sévérité de la maladie suggère son influence sur l'évolution de l'histoire naturelle de la maladie. Ces travaux de thèse ont permis de caractériser plusieurs marqueurs non-invasifs cliniquement pertinents pour améliorer le suivi des patients atteints d'HCB et aider à la décision d'initier un traitementChronic hepatitis B (CHB) infection is associated with an increased risk of cirrhosis and hepatocellular carcinoma. The aim of my thesis was to study both host and viral non-invasive markers to predict i) the viral reactivation in asymptomatic HBeAg negative patients and ii) the severity of liver fibrosis. A total of 129 and 377 patients were respectively included in the two studies. First, a combination of HBsAg > 1000 IU/mL and HBV-DNA > 200 IU/mL at the first visit, allows to identify HBeAg negative CHB patients who are at high risk of reactivation with a high sensitivity (92 %) and negative predictive value (NPV, 96 %). These patients will benefit from a treatment to limit the progression of liver disease. Interestingly, a single HBsAg measurement < 1000 UI/mL or an annual decrease > 0. 3 logioUl/mL predict HBsAg seroclearance (PPV: 89 %, NPV: 95 %). We next investigated factors associated with significant fibrosis (METAVIR >F2). Advanced age (p < 0. 0001), ALT level (p = 0. 02), HBV-DNA viral load (p = 0. 0006) and the presence of HBV variants (basal core promoter (BCP) and precore (PC), p < 0. 0001) are independently associated with significant fibrosis (METAVIR >F2). The combination of these 4 non-invasive variables accurately predicts significant fibrosis (c-index = 0. 76 [95% IC 0. 71-0. 81]) in CHB patients. The strong association of the BCP mutation with the severity of the disease suggests its impact on the natural history of CHB. In this work, we characterized several non-invasive markers clinically relevant to improve the management of CHB patients in particular regarding the decision to initiate a treatment
Book chapters on the topic "Inactive surface mutants"
1
Thosar, Nilima, Shailja Chatterjee, and Priyanka Bhaje. "Vaccination in Children/Caries Vaccine." In Illustrated Pediatric Dentistry - Part 3, 367–88. BENTHAM SCIENCE PUBLISHERS, 2023. http://dx.doi.org/10.2174/9789815080803123030022.
Full textAbstract:
Vaccination is an important measure that is undertaken to provide an individual with acquired immunity against a variety of diseases which may result in significant morbidity and sometimes, may even result in mortality. The vaccination program undertaken by Government has helped in containing many diseases which were responsible for many fatalities in the past. Like any other branch of science, vaccines are also evolving with continuous advancements in their mode of synthesis as well as the method of delivery.Even though various approaches to caries prevention are available, dental caries is still considered to be an irreversible, and a prevalent disease among humans mankind. Mutans streptococci are responsible for such activity. Biofilm is formed on the tooth surface due to everyday diet consumption followed by the role of mutans streptococci through the entry into biofilm on the tooth surface. Most treatment options or medications work for the disposal or destruction of this microorganism. The concept of immunization can be the alternative that works on either inactive or passive grounds. Certain molecular determinants of mutans streptococci are studied and considered for caries formation. Therefore, their use in the preparation of the caries vaccine is widely researched.